Effects of totally implantable venous access ports on complications and quality of life in gastrointestinal cancer chemotherapy

Table 1 Comparison of demographic characteristics between two groups, n (%)

Parameters	PICC group (n = 199)	TIVAP group (n = 147)	t/χ2	P value
Age (years)	64.48 ± 13.42	64.87 ± 12.96	0.268	0.789
Male/female	107 (53.77)/92 (46.23)	81 (55.10)/66 (44.90)	0.061	0.806
BMI (kg/m²)	28.78 ± 5.97	27.56 ± 6.14	1.853	0.065
Ethnicity			1.512	0.219
Han	153 (76.88)	121 (82.31)
Others	46 (23.12)	26 (17.69)
Smoking history			0.217	0.641
Yes	83 (41.71)	65 (44.22)
No	116 (58.29)	82 (55.78)
Drinking history			0.073	0.787
Yes	134 (67.34)	101 (68.71)
No	65 (32.66)	46 (31.29)
Diabetes history			0.242	0.623
Yes	52 (26.13)	35 (23.81)
No	147 (73.87)	112 (76.19)
Hypertension history			0.889	0.346
Yes	36 (18.09)	21 (14.29)
No	163 (81.91)	126 (85.71)
Allergy history			1.456	0.228
Yes	43 (21.61)	40 (27.21)
No	156 (78.39)	107 (72.79)
Taking fluorouracil			0.013	0.910
Yes	122 (61.31)	91 (61.90)
No	77 (38.69)	56 (38.10)
Past history of thrombosis			2.527	0.112
Yes	52 (26.13)	50 (34.01)
No	147 (73.87)	97 (65.99)
Past history of hemorrhage			0.257	0.612
Yes	35 (17.59)	29 (19.73)
No	164 (82.41)	118 (80.27)
CVAD history			0.035	0.851
Yes	168 (84.42)	123 (83.67)
No	31 (15.58)	24 (16.33)
Planned treatment mode			0	1.000
Inpatient	6 (3.02)	5 (3.40)
Outpatient	193 (96.98)	142 (96.60)

PICC: Peripherally inserted central catheter; TIVAP: Totally implantable venous access ports; BMI: Body mass index; CVAD: Central venous access device.